TI
About
TiumBio is an R&D company that creates innovative new drugs. The company provides services for cancer, hemophilia, type 2 diabetes, and idiopathic pulmonary fibrosis. TiumBio develops NCE401, NCE403, NBP604, and NBP611. NCE401 is a substance for the treatment of fibrosis while NCE403 is for treating endomitriosis, NBP604 is for hemophilia and works a neutralizing antibody, and lastly NBP611, for the treatment of hemophilia B.
Investment Focus
- Sectors
- healthtech
- Location
- Seongnam, South Korea
Contact Information
linkedin.com/in/••••••••
Find more investors like TiumBio
Search Investors